UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - drug+delivery
66
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
A Novel “Host-Guest”-Based Supramolecular Hydrogel for Dental Pulp Regeneration (Case No. 2023-154)
Summary: Researchers in the Department of Dentistry at UCLA have developed an innovative hydrogel for a vast array of biomedical and tissue engineering applications. Background: Hydrogels have emerged as powerful tools in biomedical engineering due to their ability to provide a supportive environment for cell growth, tissue repair, and
drug delivery
....
Published: 10/14/2024
|
Inventor(s):
Alireza Moshaverinia
,
Weihao Yuan
Keywords(s):
anti-dehydration
,
Drug Delivery
,
dynamic identification
,
hydrogel
,
Stem Cells / Regenerative Medicine
,
Targeted Therapy
,
tissue regeneration
Category(s):
Chemical
,
Materials > Functional Materials
,
Platforms >
Drug Delivery
,
Platforms >
Drug Delivery
> Antibody Delivery Platforms
,
Platforms >
Drug Delivery
> Nanoparticles
,
Platforms >
Drug Delivery
> Viral Delivery Systems
,
Therapeutics > Cell Therapy
,
Therapeutics > Medication
,
Therapeutics > Stem Cells And Regenerative Medicine
Targeted Delivery of IFN-gamma Using Antibody Fusion Proteins (UCLA Case No. 2017-543)
UCLA researchers in the Departments of Microbiology, Immunology & Molecular Genetics (MIMG) and Medicine have developed antibody–cytokine fusion proteins that enable the targeted delivery of active interferon-gamma (IFNγ) for cancer treatment. Interferon-gamma (IFNγ), a type II interferon, is a cytokine released by both natural...
Published: 2/26/2024
|
Inventor(s):
Sherie Morrison
,
John Timmerman
,
Kham (Ryan) Trinh
Keywords(s):
Antibody Delivery Platforms
,
Drug Delivery
,
Immunotherapy
,
Life Science Research Tools
,
Therapeutics & Vaccines
Category(s):
Therapeutics
,
Platforms >
Drug Delivery
,
Platforms >
Drug Delivery
> Antibody Delivery Platforms
,
Life Science Research Tools
,
Therapeutics > Immunology And Immunotherapy
Intelligent Stent System for Chronic On-Demand
Drug Delivery
(Case No. 2021-069)
Summary: UCLA researchers in the Department of Neurology have developed an intelligent stent system for chronic on-demand
drug delivery
, addressing the challenge of the blood-brain barrier hindering drug therapy in the central nervous system. Background: The blood-brain barrier poses a significant obstacle to effective drug delivery to the central...
Published: 7/9/2024
|
Inventor(s):
Jose Morales
,
Haotian Lu
,
Huachen Cui
,
Xiaoyu (Rayne) Zheng
Keywords(s):
blood flow management
,
blood-brain barrier
,
Drug
,
Drug Delivery
,
Drug monitoring
,
Invasiveness Of Surgical Procedures
,
MEMS
,
minimally invasive device
,
minimally invasive
drug delivery
systems
,
neural signals
,
neural stimulation
,
Neurocognitive
,
Neurodegeneration
,
neurological disorders
,
Neurology
,
neuro-oncology
,
Neuropathology
,
Neurosurgery
,
non-invasive
,
non-invasive drug monitoring
,
on-demand
drug delivery
,
Pharmaceutical Drug
,
piezoelectric ultrasound transducers
Category(s):
Platforms
,
Platforms >
Drug Delivery
,
Medical Devices
,
Therapeutics
,
Therapeutics > CNS and Neurology
,
Therapeutics > Oncology
,
Therapeutics > Musculoskeletal Disease
2022-223 A Bioanalytics-Enabled and Hollow Microneedle-Based Wearable Technology for Personalized Medicine
Summary: UCLA researchers in the Department of Electrical and Computer Engineering have developed a minimally-invasive wearable device that continuously monitors pharmaceutical concentrations in a user to optimize the drug’s dosage. Background: The annual cost of medication-related morbidity and mortality due to non-optimized pharmacotherapy...
Published: 7/19/2023
|
Inventor(s):
Sam Emaminejad
,
Shuyu Lin
Keywords(s):
Adverse Drug Reaction
,
Antibody-Drug Conjugate
,
Antiviral Drug
,
Biomonitoring
,
Blood Glucose Monitoring
,
Drug
,
Drug Carrier
,
Drug Delivery
,
Drug Delivery
Microporous Material
,
Drug Development
,
Drug Development Feature Extraction
,
Drug Discovery
,
Drug monitoring
,
Drug Resistance
,
Drug-Eluting Stent
,
Extensively Drug-Resistant Tuberculosis
,
Fine-Needle Aspiration
,
Gene Combination Drug
,
Immunosuppressive Drug
,
interstitial fluid (ISF)-based information
,
Investigatioal New Drug
,
Management Of HIV/AIDS Psychoactive Drug
,
medical automation technology
,
Medical Device
,
Medical Devices and Materials
,
medication customization
,
medication efficacy
,
Microneedle array
,
minimally invasive device
,
Monitoring (Medicine)
,
Monitoring And Recording Systems
,
Multiple Drug Resistance
,
Mutation Drug Design
,
Nanosensor
,
Nanostructure
,
Nanotechnology
,
non-invasive drug monitoring
,
personalized dose assessment
,
Pharmaceutical Drug
,
Pharmaceutical Drug Ethylene Glycol
,
Pharmaceutical Drug Opioid Dependence
,
Prescription Drug
,
real-time sensing/monitoring/tracking
,
remote monitoring
,
sample-to-answer devices
,
Smart medical device
,
Therapeutic Drug Monitoring
,
wearable medical device
Category(s):
Mechanical
,
Mechanical > Sensors
,
Medical Devices
,
Medical Devices > Monitoring And Recording Systems
,
Platforms >
Drug Delivery
,
Software & Algorithms > Bioinformatics
,
Software & Algorithms > Artificial Intelligence & Machine Learning
,
Electrical > Sensors
,
Materials > Nanotechnology
2020-922 A Universal Designed Protein Cage for Sensing and Responding to Any Other Protein Molecule
SUMMARY: UCLA researchers in the Department of Chemistry and Biochemistry have designed and developed a protein cage which can be easily tailored to sense other proteins, opening in response, and thus delivering enclosed biological compounds across a wide variety of applications, including biosensing, molecular diagnostics, and targeted
drug delivery
....
Published: 9/5/2023
|
Inventor(s):
Todd Yeates
Keywords(s):
Diagnostic Markers & Platforms
,
Diagnostic Platform Technologies (E.G. Microfluidics)
,
Diagnostic Test
,
Drug Delivery
Category(s):
Medical Devices
,
Medical Devices > Monitoring And Recording Systems
,
Platforms >
Drug Delivery
,
Platforms >
Drug Delivery
> Nucleic Acid Platform Systems
,
Platforms >
Drug Delivery
> Nanoparticles
,
Platforms >
Drug Delivery
> Nucleic Acids
2022-222 A Wearable Aptamer Microneedle Patch for Continuous Minimally-Invasive Biomonitoring
Summary: UCLA researchers in the Department of Bioengineering have developed a novel wearable device for real-time, minimally-invasive medication monitoring. Background: Current medication dosing is determined by taking the average therapeutic dose of a small patient sample size. However, this is often inaccurate for many individuals and the recommended...
Published: 8/2/2024
|
Inventor(s):
Sam Emaminejad
,
Shuyu Lin
,
Jialun Zhu
,
Xuanbing Cheng
Keywords(s):
Biomonitoring
,
Drug
,
Drug Delivery
,
Drug Development
,
Drug Discovery
,
Drug Resistance
,
Invasiveness Of Surgical Procedures
,
Microneedle array
,
non-invasive drug monitoring
,
Personalized Pharmacotherapy
,
Pharmaceutical Drug
,
Pharmacokinetics
,
Pharmacology
,
Prescription Drug
,
Therapeutic Drug Monitoring
,
Therapeutics & Vaccines
Category(s):
Life Science Research Tools
,
Medical Devices
,
Materials > Nanotechnology
Optimized Lentiviral Vector for Stem Cell Gene Therapy of Hemoglobinopathies
UCLA Case No. 2017-460 Summary UCLA researchers in the Department of Microbiology, Immunology and Molecular Genetics have developed a novel method to produce short lentiviral vectors with tissue-specific expression, with a primary focus on lentiviral vectors for treating sickle cell disease and other disorders of hemoglobin. Background Sickle...
Published: 1/23/2024
|
Inventor(s):
Donald Kohn
,
Roger Hollis
,
Richard Morgan
Keywords(s):
Drug Delivery
,
Gene Editing Systems
,
Gene Therapy
,
Genetic Disease
,
Life Science Research Tools
,
Plasmids / Vectors
,
Research Methods
,
Therapeutics & Vaccines
,
Viral Delivery Systems
Category(s):
Life Science Research Tools > Plasmids/Vectors
,
Life Science Research Tools
,
Life Science Research Tools > Research Methods
,
Platforms >
Drug Delivery
,
Therapeutics
,
Platforms >
Drug Delivery
> Viral Delivery Systems
,
Therapeutics > Gene Therapy And Editing
2018-438 A DNA CONSTRUCT FOR TARGETING THERAPEUTIC MOLECULES TO DISEASED TISSUE BY IMMUNE CELLS
INTRODUCTION:UCLA researchers in the Departments of Integrative Biology & Physiology and Pathology & Laboratory Medicine have developed a novel construct for targeting therapeutic biological molecules specifically to diseased tissue, using immune cells as a delivery system. BACKGROUND:
Drug delivery
is the process of administering a pharmaceutical...
Published: 7/19/2023
|
Inventor(s):
Keywords(s):
Drug Delivery
,
Nucleic Acid Platform Systems
,
Nucleic Acids
,
Therapeutics & Vaccines
Category(s):
Platforms >
Drug Delivery
> Nucleic Acid Platform Systems
,
Platforms >
Drug Delivery
> Nucleic Acids
2021-092 FLOW REGULATION MECHANISM FOR COMPARTMENTALIZED LUNG VENTILATION
SUMMARY: UCLA researchers in the Department of Pulmonary and Clinical Care have developed a device capable of analyzing individual lungs in real-time to improve the quality of care for mechanically ventilated patients. BACKGROUND: Ventilators aid patients that have difficulty breathing by pressing positive air pressure into their lungs. Mechanical...
Published: 7/19/2023
|
Inventor(s):
Keywords(s):
Angiogenesis Acute Lung Injury
,
Diagnostic Test
,
Drug Delivery
,
Instrumentation
,
Lung
,
Lung Pulmonology
,
Medical Device
,
Medical Imaging
,
Monitoring And Recording Systems
,
Respiratory & Pulmonary
,
Sensors
,
Software
Category(s):
Medical Devices
,
Medical Devices > Medical Imaging
,
Medical Devices > Monitoring And Recording Systems
,
Therapeutics > Infectious Diseases > COVID
,
Therapeutics > Respiratory And Pulmonary
,
Software & Algorithms > Programs
2020-426 PRODRUGS OF PERIPHERALLY-ACTING CANNABINOID RECEPTOR AGONISTS FOR CHRONIC PAIN
Researchers at UCLA have developed prodrugs of peripherally-acting cannabinoid (PRCBs) receptor agonists for chronic pain relief. BACKGROUND: Cannabinoids are becoming prevalent in chronic pain treatments even though current marketed cannabinoid compounds may cause psychotropic effects or central nervous system (CNS)-mediated side effects. A potential...
Published: 9/5/2023
|
Inventor(s):
Igor Spigelman
,
Alexander Spokoyny
,
Herbert Seltzman
Keywords(s):
Cns
,
Drug Delivery
,
Therapeutics & Vaccines
Category(s):
Platforms >
Drug Delivery
,
Therapeutics
,
Therapeutics > CNS and Neurology
1
2
3
4
5
6
7